A new Cat antiviral that inhibits SARS-CoV-2 rapidly-tracked for human clinical trials may be just what we need to beat the disease. The virus causes fever and cough in humans, yet it is still not known exactly how to stop its progress in humans. It was discovered by accident, after a lab worker fell ill in China.
Symptoms of the virus include a severe case of cough, fever, fatigue, and shortness of breath; and more serious respiratory illness, including pneumonia, acute hepatitis, and acute kidney failure. If you are sick with the SARS-CoV-2 virus and have caught it from a person who has the disease, you need to visit a doctor right away.
Scientists have already developed an antiviral drug to treat SARS, but because of the slow progress of the drug, only a handful of people have access to the drugs. The reason is that this drug doesn’t have much activity in cats or dogs.
Antiviral drugs are usually given to animals after they have contracted the disease. That way, they can help stop the infection before it spreads to humans. It’s possible that if the drug is used on humans as well, we may be able to cure SARS in its early stages.
Antiviral drugs are designed to block the replication of the virus. This is important because once you have caught the virus, there is no getting the infection under control because it has spread throughout the body.
Because antiviral drugs work by blocking replication, they stop the virus from causing any symptoms. And since the symptoms caused by SARS-CoV-2 have already started to show up, they stop their development and therefore they do not cause further illness. Even so, antiviral drugs don’t always have a complete effect on every individual person. Some people may experience some improvement after they have taken one or two pills.
Scientists have been looking for a way to slow down the progression of the SARS-CoV-2 virus. The new Cat antiviral that inhibits SARS-CoV-2 fast-tracked for human clinical trials might have found it. It’s called Zmappo. This virus-inhibiting antiviral is being evaluated in the US by the FDA.
The Zmappo antiviral blocks the replication of the virus and stops the viral replication machinery in the middle layer of the skin (the epidermis) of the infected animal. The drug has already been approved by the FDA to be useful against SARS, but in order to make it effective, it has to be administered to animals with SARS, like dogs and cats.
There are two different phases of clinical testing for Zmappo. In the first phase of the clinical testing, it was shown to be safe and effective in the mice.
In the second phase of testing, the scientists are trying to determine if the drug is even useful in humans. That is to see if the drug can block the virus in the skin and other places where it spreads, like the respiratory tract, the skin or the urinary tract. if it can even stop the virus from reproducing in the first place.
If Zmappo does work in humans, it could lead to the elimination of SARS-CoV-2. Since there have been no reported cases of it being harmful in humans, it’s a very exciting development. For those who think SARS-CoV-2 is a long way off from eradication, you have a lot to look forward to!
The only concern about Zmappo is that it hasn’t been proven effective in humans yet. But it’s still a good candidate for human clinical trials.
When you consider all of the benefits this antiviral has to offer, and the fact that there haven’t been any reported side effects at all in humans so far, it’s easy to see why this antiviral has become one of the most promising anti-SARS treatments. It also has to be noted that no one is 100% sure about the safety of Zmappo in cats. as there are no studies done on people using the drug in humans. But if the results are positive, this cat antiviral could be the answer you have been looking for in your fight against the virus.